As of May 3, 2024, the Incyte stock's PE ratio is 16.14. This results from the current EPS of $3.33 and stock price of $53.76. The P/E ratio has decreased by 41% from the past four quarters average of 27.3.
The PE ratio of Incyte has averaged 237.56 over the last nine years. The current PE ratio of 16.14 is 93% below the historical average. In the past nine years, INCY's PE ratio was at its highest in the Dec 2015 quarter at 2,711.25, when the stock price was $108.45 and the EPS was $0.04. The lowest value was in the Sep 2022 quarter, when it reached 16.83 with a price of $66.64 and an EPS of $3.96.
Maximum annual increase: 207.56% in 2022
Maximum annual decrease: -93.28% in 2016
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 23.52 | -55.2% |
| 2022 | 52.5 | 207.56% |
| 2021 | 17.07 | N/A |
| 2020 | N/A | N/A |
| 2019 | 41.98 | -65.67% |
| 2018 | 122.29 | N/A |
| 2017 | N/A | N/A |
| 2016 | 182.31 | -93.28% |
| 2015 | 2,711.25 | N/A |
| 2014 | N/A | N/A |
Currently, INCY's PE ratio is lower than the 3, 5 and 10-year averages.
INCY's PE ratio is lower than its peer stocks LLY and AMGN, but it is greater than NVS's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVS Novartis AG | 13.13 | $198.47B |
| INCY Incyte Corp | 16.14 | $12.07B |
| AMGN Amgen Inc | 44.22 | $166.99B |
| PFE Pfizer Inc | 73.18 | $157.04B |
| LLY ELI LILLY & Co | 107.77 | $698.52B |
| LGND Ligand Pharmaceuticals Inc | N/A | $1.31B |
| ARDX Ardelyx Inc | N/A | $2.04B |
| GERN Geron Corp | N/A | $2.33B |
INCY stock has a price to earnings ratio of 16.14 as of May 3, 2024.
As an average over the last 3 years, INCY stock has a PE ratio of 30.38.
As an average over the last 5 years, INCY stock has a PE ratio of 33.86.
Over the last nine years, the quarterly PE ratio reached a historic high of 2,711.25 in the Dec 2015 quarter.
INCY's price to earnings ratio is currently 93% below its 9-year historical average.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (May 3, 2024), Incyte's stock price is $53.76. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $3.33. Therefore, Incyte's P/E ratio for today is 16.14. PE RATIO(16.14) = STOCK PRICE($53.76) / TTM EPS($3.33)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.